Key Highlights
- $15 million raised in Series B funding to expand musculoskeletal (MSK) care innovations.
- Funding led by A1 Health Ventures, with participation from Polaris Partners, Providence Ventures, and others.
- Plans to enhance care delivery for over 4 million people through innovative partnerships.
Source: Business Wire
Notable Quotes
- “At Livara, we are building a better musculoskeletal management solution, taking a biopsychosocial approach to patient care,” – Rob Cohen, Chief Executive Officer at Livara Health
- “We believe their virtual and in-person care delivery and care navigation solutions will have an enormous impact on the state of musculoskeletal care in the U.S.,” – Jon Phillips, Managing Director at A1 Health Ventures
SoHC's Take
The substantial investment in Livara Health underscores the increasing recognition of value-based care models in managing chronic conditions like musculoskeletal disorders. With a proven track record and a strategic expansion plan, Livara is well-positioned to lead transformative changes in healthcare delivery. The move not only reflects investor confidence but also signals a significant shift towards integrated care models that promise better patient outcomes and cost efficiencies. As healthcare continues to evolve, Livara’s approach could set a new standard in MSK management, benefiting millions of patients across the U.S.
